Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Mingdu Tech Completes $14 Million Series A to Develop Efficient Pharma Programs

publication date: Jul 26, 2019

Zhejiang Mingdu Zhikong Technology raised $14 million in a Series A that it will use to advance its smart manufacturing programs for pharmaceutical development, production and distribution, which it offers to pharmas. The A round was led by Cash Capital and included Collaborative Innovation Investment. Mingdu Tech will also use the funds for promotion and development of the improved programs. Founded in 2017, Mingdu Tech uses AI and big data to develop its offerings. More details....


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital